Pencapaian Life Sciences Mengumumkan Publikasi Hasil Uji Coba Berhenti Vaping dengan Cytisinicline di JAMA Internal Medicine oleh Investing.com
; cytisinicline and its other operations; the risk that cytisinicline may not receive regulatory approval or be successfully commercialized; the risk that Achieve may not be able to successfully market cytisinicline; the risk that new developments in the smoking cessation market may render cytisinicline uncompetitive or obsolete; the risk that Achieve may not be able … Baca Selengkapnya